Features of diagnosis and treatment of vertebrogenic pain syndromes in elderly patients


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Back pain is one of the most frequent complaints of elderly patients, but until recently this problem did not attract proper attention. In part, this is true: at least one episode of back pain occurs within a year in 30-50% of patients older than 70 years. However, the clinical relevance of back pain in the elderly is more significant. In the context of more frequent comorbid conditions and lower socioeconomic status, it has a more negative impact on the quality of life, restricts mobility and independence in daily activities to a greater extent, and is an immediate factor that increases the risk of falls, and causes a persistent fear of movement due to ability to fall and be injured, which closes the vicious circle of inactivity. In conditions of low mobility and limited pharmacotherapy, the tendency to chronization of pain syndrome is increasing.

Texto integral

Acesso é fechado

Sobre autores

Oleg Levin

Russian Medical Academy of Continuous Professional Education

Email: neurolev@mail.ru
MD, Professor, Head of the Department of Neurology

Bibliografia

  1. Левин О.С., Штульман Д.Р. Неврология. М., 2016. 1090 с.
  2. Подчуфарова Е.В., Яхно Н.Н. Боль в спине. М., 2010. 368 с.
  3. Apkarian A., Robinson J. Low back pain. IASP Pain Clinical Updates. 2010;XVIII(6):1-6.
  4. Chou R., Qaseem A., Snow V. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society. Ann. Intern. Med. 2007;147:478-91.
  5. Chou R., Qaseem A., Owens D. Diagnostic Imaging for Low Back Pain: Advice for High-Value HealthCare From the American College of Physicians. Ann. Intern. Med. 2011;154:181-89.
  6. Cohen S., Raja S. Pathogenesis, Diagnosis, and Treatment of Lumbar Zygapophysial (Facet Joint Pain.Anesthesiol. 2007;106: 591-614.
  7. McAlindon T.E., Bannuru R.R., Sullivan M.C., et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr. Cartil. 2014;22:363-88.
  8. Fukuzaki K., Koja T., Kamenosono T., et al. General pharmacological studies of Lornoxicam. Japan. Pharm. Therap. 1997;25(2):81-101.
  9. Kullich W., Klein G. Influence of the nonsteroidal antiinflammatory drug lornoxicam on the secretion of the endogenous opiate peptides dynorphin and beta-endorphin. Akt. Rheum. 1992;17:128-32.
  10. Charlot J. Long term efficacy and tolerability of lornoxicam in elderly patients with rheumatoid arthritis or osteoarthritis: a multicenter, open study. Hafslund. Nycomed Pharma AG. Data on file 2001.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies